Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer

Background: Aberrant methylation and expression of various noncoding RNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), confer a great potential as tumor markers. This study aimed to investigate miR-30b DNA methylation and metastasis associated lung adenocarcinoma transcript 1 (MA...

Full description

Saved in:
Bibliographic Details
Main Authors: Marziyeh Memarzadeh, Habib Zarredar, Milad Asadi, Armin Sadeghi, Venus Zafari, Shahryar Hashemzadeh, Hamed Sabbagh-Jadid, Mortaza Raeisi
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2025-04-01
Series:Middle East Journal of Cancer
Subjects:
Online Access:https://mejc.sums.ac.ir/article_50236_38dc29b1d2af2e7f9a0f8e94d34c4c9a.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849731915397988352
author Marziyeh Memarzadeh
Habib Zarredar
Milad Asadi
Armin Sadeghi
Venus Zafari
Shahryar Hashemzadeh
Hamed Sabbagh-Jadid
Mortaza Raeisi
author_facet Marziyeh Memarzadeh
Habib Zarredar
Milad Asadi
Armin Sadeghi
Venus Zafari
Shahryar Hashemzadeh
Hamed Sabbagh-Jadid
Mortaza Raeisi
author_sort Marziyeh Memarzadeh
collection DOAJ
description Background: Aberrant methylation and expression of various noncoding RNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), confer a great potential as tumor markers. This study aimed to investigate miR-30b DNA methylation and metastasis associated lung adenocarcinoma transcript 1 (MALAT-1) expression patterns as potential diagnostic biomarkers for non-small cell lung cancer (NSCLC).Method: In this cross-sectional study, miR-30b DNA methylation and MALAT-1 expression patterns were first explored using microarray data retrieved from the NSCLC dataset in the Cancer Genome Atlas (TCGA)-LUNG. Then, the obtained results were further validated in internal samples. Subsequently, genomic DNA was extracted and modified by sodium bisulfite to determine DNA methylation using q-MSP. Total RNA was extracted and transcribed to cDNA to measure transcription level by quantitative real-time polymerase chain reaction. GraphPad 6 Prism v.8 was used to perform the statistical analyses. Comparisons between groups in internal samples were conducted by paired student's t-test, while Mann-Whitney U test was used to analyze TCGA-LUNG data (P < 0.05).Results: Our results indicated miR-30b hypermethylation, miR-30b downregulation and lncRNA MALAT-1 overexpression in NSCLC tumor samples compared with marginal normal samples. These changes were significantly associated with the stage of malignancy like lymph node metastasis. Also, using receiver operating characteristic curve analysis, MALAT-1 expression, and miR-30b methylation and expression patterns were found as possible diagnostic biomarkers for NSCLC (area under the curve was 0.70, 0.67, and 0.74, respectively).Conclusion: We found involvement of miR-30b hypermethylation and downregulation as well as lncRNA MALAT-1 overexpression with tumor outcomes of NSCLC patients.
format Article
id doaj-art-1a10fb1d9e334481aa2d54869c6f31a2
institution DOAJ
issn 2008-6709
2008-6687
language English
publishDate 2025-04-01
publisher Shiraz University of Medical Sciences
record_format Article
series Middle East Journal of Cancer
spelling doaj-art-1a10fb1d9e334481aa2d54869c6f31a22025-08-20T03:08:24ZengShiraz University of Medical SciencesMiddle East Journal of Cancer2008-67092008-66872025-04-0116212713810.30476/mejc.2024.101524.203550236Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung CancerMarziyeh Memarzadeh0Habib Zarredar1Milad Asadi2Armin Sadeghi3Venus Zafari4Shahryar Hashemzadeh5Hamed Sabbagh-Jadid6Mortaza Raeisi7Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IranTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Basic Oncology of Health Institute of Ege University, Izmir, TurkeyTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IranDepartment of Basic Oncology of Health Institute of Ege University, Izmir, TurkeyTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IranTuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, IranHematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, IranBackground: Aberrant methylation and expression of various noncoding RNAs, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), confer a great potential as tumor markers. This study aimed to investigate miR-30b DNA methylation and metastasis associated lung adenocarcinoma transcript 1 (MALAT-1) expression patterns as potential diagnostic biomarkers for non-small cell lung cancer (NSCLC).Method: In this cross-sectional study, miR-30b DNA methylation and MALAT-1 expression patterns were first explored using microarray data retrieved from the NSCLC dataset in the Cancer Genome Atlas (TCGA)-LUNG. Then, the obtained results were further validated in internal samples. Subsequently, genomic DNA was extracted and modified by sodium bisulfite to determine DNA methylation using q-MSP. Total RNA was extracted and transcribed to cDNA to measure transcription level by quantitative real-time polymerase chain reaction. GraphPad 6 Prism v.8 was used to perform the statistical analyses. Comparisons between groups in internal samples were conducted by paired student's t-test, while Mann-Whitney U test was used to analyze TCGA-LUNG data (P < 0.05).Results: Our results indicated miR-30b hypermethylation, miR-30b downregulation and lncRNA MALAT-1 overexpression in NSCLC tumor samples compared with marginal normal samples. These changes were significantly associated with the stage of malignancy like lymph node metastasis. Also, using receiver operating characteristic curve analysis, MALAT-1 expression, and miR-30b methylation and expression patterns were found as possible diagnostic biomarkers for NSCLC (area under the curve was 0.70, 0.67, and 0.74, respectively).Conclusion: We found involvement of miR-30b hypermethylation and downregulation as well as lncRNA MALAT-1 overexpression with tumor outcomes of NSCLC patients.https://mejc.sums.ac.ir/article_50236_38dc29b1d2af2e7f9a0f8e94d34c4c9a.pdfmir-30blncrna malt-1dna methylationcarcinoma, non-small-cell lung, neoplasms
spellingShingle Marziyeh Memarzadeh
Habib Zarredar
Milad Asadi
Armin Sadeghi
Venus Zafari
Shahryar Hashemzadeh
Hamed Sabbagh-Jadid
Mortaza Raeisi
Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
Middle East Journal of Cancer
mir-30b
lncrna malt-1
dna methylation
carcinoma, non-small-cell lung, neoplasms
title Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
title_full Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
title_fullStr Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
title_full_unstemmed Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
title_short Exploring miR-30b Methylation and MALAT-1 Expression as Diagnostic Biomarkers for Non-Small Cell Lung Cancer
title_sort exploring mir 30b methylation and malat 1 expression as diagnostic biomarkers for non small cell lung cancer
topic mir-30b
lncrna malt-1
dna methylation
carcinoma, non-small-cell lung, neoplasms
url https://mejc.sums.ac.ir/article_50236_38dc29b1d2af2e7f9a0f8e94d34c4c9a.pdf
work_keys_str_mv AT marziyehmemarzadeh exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT habibzarredar exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT miladasadi exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT arminsadeghi exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT venuszafari exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT shahryarhashemzadeh exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT hamedsabbaghjadid exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer
AT mortazaraeisi exploringmir30bmethylationandmalat1expressionasdiagnosticbiomarkersfornonsmallcelllungcancer